Aurinia initiates PRESERVE Phase 4 study of LUPKYNIS combination therapy in lupus nephritis

Anixa Biosciences advances ovarian cancer CAR-T trial to highest dose level

Taiwan biomedical startups hold over 100 business meetings at BIO 2026

Brii Bio reports Phase 2 end-of-treatment data in chronic hepatitis B

Nona Biosciences names new chief operating officer

SK bioscience to lead Gates Foundation-funded ROTOR project

Data from Partner Therapeutics' eNRGy trial of zenocutuzumab published in Journal of Clinical Oncology

Arcturus Therapeutics and Thermo Fisher enter strategic collaboration on ARCT-032 development

Genentech reports positive Phase III results for divarasib in KRAS G12C lung cancer

Neurocrine Biosciences initiates crinecerfont Phase 2 study in young children with classic CAH

Abbisko Therapeutics and AstraZeneca collaborate to conduct combination clinical trial for NSCLC

Cumberland Pharmaceuticals sharpens focus on rare disease pipeline with USD100m sale of branded US business to Apotex

Ipsen to acquire Memo Therapeutics to expand rare disease portfolio

Eurobio Scientific completes acquisition of CareDx's transplant lab products business

Aspen Neuroscience completes Cohort 3 and 4 dosing in Parkinson's disease trial